Dr Alfred Mangani
Regulatory and Surveillance Office, Department of Drug Information Zambia Medicines Regulatory Authority (ZAMRA)
Dr. Alfred Mangani is a Regulatory and Surveillance Officer, Department of Drug Information at Zambia Medicines Regulatory Authority (ZAMRA) and a postgraduate of Pharmacology with years of clinical trial and academic research experience. He is a veterinarian by training with a vast knowledge of preclinical studies and has carried out several preclinical studies.
He is currently working on Adverse Event Following Immunization (AEFIs) associated with Covid-19 Vaccines and Adverse Events related to Isoniazid Preventive Therapy (IPT). He has published several studies including “Bovine Leukemia Virus, Infectious Bursal Disease and Adverse Events Associated with Dolutegravir”.
